IDO1 and psoriasis: IDOC4S4 was observed to be the most stable variant at reduced (4 °C) and body (37 °C) temperatures and outperformed wild-type IDO domain in the fusion protein IDO-galectin3 (IDO-Gal3) in vivo in an imiquimod (IMQ)-induced psoriasis mouse model.